
|Videos|December 13, 2016
The Microbiome and Outcomes After Allogeneic Transplant
Author(s)Robert Jenq, MD
In this interview we discuss advances in the relationship between the microbiome and outcomes after allogeneic transplant, including graft-vs-host disease and relapse.
Advertisement
In this video, Robert Jenq, MD, of the Memorial Sloan Kettering Cancer Center, discusses advances in the relationship between the microbiome and outcomes after allogeneic transplant, including graft-vs-host disease and relapse.
Dr. Jenq spoke at an education session on improving outcomes of bone marrow transplants in patients with hematologic malignancies at the 58th Annual Meeting of the American Society of Hematology, held December 3–6 in San Diego, California.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Considering CAR T vs Bispecific Antibodies in R/R Follicular Lymphoma
2
First-in-Human mKRAS Vaccine Elicits Durable T-Cell Responses in High-Risk PDAC
3
How Do Updated NCCN Guidelines and ctDNA Data Reshape MIBC Treatment?
4
Half a Year Into the Breast Biopsy Needle Shortage, Clinicians Lean on Networks, Not Workarounds
5






















































